Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study

JOURNAL ARTICLE published March 2023 in Cancer Medicine

Authors: Takeshi Hatanaka | Satoru Kakizaki | Atsushi Hiraoka | Toshifumi Tada | Masashi Hirooka | Kazuya Kariyama | Joji Tani | Masanori Atsukawa | Koichi Takaguchi | Ei Itobayashi | Shinya Fukunishi | Kunihiko Tsuji | Toru Ishikawa | Kazuto Tajiri | Hironori Ochi | Satoshi Yasuda | Hidenori Toyoda | Chikara Ogawa | Takashi Nishimura | Noritomo Shimada | Kazuhito Kawata | Hisashi Kosaka | Takaaki Tanaka | Hideko Ohama | Kazuhiro Nouso | Asahiro Morishita | Akemi Tsutsui | Takuya Nagano | Norio Itokawa | Tomomi Okubo | Taeang Arai | Michitaka Imai | Atsushi Naganuma | Yohei Koizumi | Shinichiro Nakamura | Kouji Joko | Masaki Kaibori | Hiroko Iijima | Yoichi Hiasa | Takashi Kumada | the Real‐life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)